Ubs Group Ag Amneal Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 21,849,523 shares of AMRX stock, worth $188 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,849,523
Previous 178,158
12164.13%
Holding current value
$188 Million
Previous $1.08 Million
12758.57%
% of portfolio
0.03%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Vanguard Group Inc Valley Forge, PA14MShares$121 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$106 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$92.4 Million2.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il9.99MShares$86.1 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...